Collective Family Office »

Halozyme Therapeutics shares owned by Collective Family Office

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Collective Family Office from 13F filings

Historical chart of Collective Family Office investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Collective Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Collective Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $324k 4.8k 67.30

More positions owned by Collective Family Office

J P Morgan Exchange Traded F Municipal Etf (JMUB)
Invesco Exch Trd Slf Idx Invsco Blsh 26 (BSJQ)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Index Fds Value Etf (VTV)
Schwab Strategic Tr Fundamental Intl (FNDF)
Global X Fds Us Pfd Etf (PFFD)
Schwab Strategic Tr Fundamental Us S (FNDA)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Schwab Strategic Tr Fundamental Intl (FNDC)
Ishares Tr Pfd And Incm Sec (PFF)
Schwab Strategic Tr Fundamental Us L (FNDX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Collective Family Office

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Arrowstreet Capital, Limited Partnership
Invesco
Snyder Capital Management
D. E. Shaw & Co
Geode Capital Management
Dimensional Fund Advisors
Alliancebernstein
Macquarie Group
Federated Investors
Hanna Zanoni
UBS Group
Two Sigma Investments

View all funds holding Halozyme Therapeutics